America; South America; Endocrinology; Genetics; Mutation; Family environment; Family study; Brazil; Symptomatology; Clinical form; Amérique; Amérique du Sud; Gène AIP; Endocrinologie; Génétique; Milieu familial; Etude familiale; Brésil; Symptomatologie; Forme clinique
Abstract :
[en] Background: Germline aryl hydrocarbon receptor-interacting protein (AIP) mutations occur in 15% of familial isolated pituitary adenoma (FIPA) cases. To date, studies have focused on the identification of such mutations in large international cohorts. Detailed genetic and clinical studies within AIP mutation-positive families have been limited.
Aim: To undertake a comprehensive study of a large Brazilian FIPA kindred with an E174 frameshift (E174fs) AIP mutation to assess clinical, hormonal, and radiological features in mutation carriers.
Methods: The kindred included 122 subjects across six generations; all underwent clinical examination. Genetic studies were performed to identify E174fs mutation carriers. E174fs-positive subjects underwent magnetic resonance imaging (MRI) and hormonal assessments.
Results: Of the ten germline AIP mutation carriers, three had pituitary tumors, while seven were asymptomatic carriers. Three patients with pituitary tumors showed variability in terms of tumor phenotype (two with acromegaly, one with prolactinoma, or mixed prolactin/GH-secreting tumor) and age at diagnosis; both patients with acromegaly had poor responses to octreotide. Tumor AIP immunohistochemistry from the operated patient showed decreased expression when compared with normal tissue. Two adult subjects with normal MRI had elevated IGF-I in the absence of other causes. A 2-year-old child with the E174fs mutation and a normal MRI had premature thelarche, ovarian development, and advanced bone age in the absence of other underlying causes.
Conclusions: The penetrance of pituitary tumors in AIP mutation-positive adult subjects was 33.3%, while clinical/hormonal features were variable. The features noted in AIP-mutation carriers in this kindred suggest that clinical characteristics of such carriers may extend beyond pituitary tumors.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Naves, Luciana Ansaneli
Daly, Adrian ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA & Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liège, Belgium. Journal of Clinical Endocrinology and Metabolism 2006 91 4769-4775.
Davis JR, Farrell WE & Clayton RN. Pituitary tumours. Reproduction 2001 121 363-371.
Barlier A, Gunz G, Zamora AJ, Morange-Ramos I, Figarella-Branger D, Dufour H, Enjalbert A & Jaquet P. Prognostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas. Journal of Clinical Endocrinology and Metabolism 1998 83 1604-1610.
Pei L & Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Molecular Endocrinology 1997 11 433-441.
Beckers A & Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. European Journal of Endocrinology 2007 157 371-382.
Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park WS, Pack S, Huang S, Agarwal SK, Guru SC, Manickam P, Debelenko LV, Kester MB, Olufemi SE, Heppner C, Crabtree JS, Burns AL, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Emmert-Buck MR, Liotta LA, Asa SL & Lubensky IA. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Research 1997 57 5446-5451.
Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA & Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PPKAR1A gene in patients with the Carney complex. Human Molecular Genetics 2000 9 3037-3046.
Frohman LA & Eguchi K. Familial acromegaly. Growth Hormone and IGF Research 2004 14 S90-S96.
Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, CalenderA, Murat A, Cavagnini F & Beckers A. Clinical characterization of familiat isolated pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2006 91 3316-3323.
Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A & Aaltonen LA. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006 312 1228-1230.
Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabate MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Werneau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova. O, Montanana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V Brue T, Bours V, Teh BT & Beckers A. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism 2007 92 1891-1896.
Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Mäkinen MJ, Tuppurainen K, Paschke R, Gimm. O, Koch CA, Günlogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P & Aaltonen LA. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. Journal of Clinical Endocrinology and Metabolism 2007 92 3321-3325.
Iwata T, Yamada S, Mizusawa N, Golam HM, Sano T & Yoshimoto K. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clinical Endocrinology 2007 66 499-502.
Toledo RA, Lourenco DM, Jr, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP & Dahia PL. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. Journal of Clinical Endocrinology and Metabolism 2007 92 1934-1937.
Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J & Atkinson MJ. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. PNAS 2006 103 15558-15563.
Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Makinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T, Robledo M, De Menis E, Weil RJ, Wasik A, Zielinski G, Lucewicz O, Lubinski J, Launonen V, Vahteristo P & Aaltonen LA. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. PNAS 2007 104 4101-4105.
Ozawa A, Agarwal SK, Mateo CM, Burns AL, Rice TS, Kennedy PA, Quigley CM, Simonds WF, Weinstein LS, Chandrasekharappa SC, Collins FS, Spiegel AM & Marx SJ. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. Journal of Clinical Endocrinology and Metabolism 2007 92 1948-1951.
Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T, Enjalbert A & Beckers A. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2007 92 1952-1955.
Gueorguiev M, Quinton R, Chapple R, Leontiou C, Lolli F, Wass JA, Popovic V, Ribeiro-Oliveira A, Gadelha MR, Clayton RN, Jordan S, Frohman LA, Grossman AB & Korbonits M. The role of AIP in familial acromegaly. The Endocrine Society 89th Annual Congress 2007, 2007 OR15-2.
Stratakis CA, Matyakhina L, Courkoutsakis N, Patronas N, Voutetakis A, Stergiopoulos S, Bossis I & Carney JA. Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex). Frontiers of Hormone Research 2004 32 253-264.
Kovacs K, Horvath E, Thorner MO & Rogol AD. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgicallyremoved adenohypophysis. Virchows Archives A, Pathological Anatomy and Histopathology 1984 403 77-86.
de Oliveira SK, Hoffmeister M, Gambaryan S, Muller-Esterl W, Guimaraes JA & Smolenski AP. Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. Journal of Biological Chemistry 2007 282 13656-13663.
Bolger GB, Peden AH, Steele MR, MacKenzie C, McEwan DG, Wallace DA, Huston E, Baillie GS & Houslay MD. Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. Journal of Biological Chemistry 2003 278 33351-33363.
Kang BH & Altieri DC. Regulation of survivin stability by the aryl hydrocarbon receptorinteracting protein. Journal of Biological Chemistry 2006 281 24721-24727.
Yano M, Terada K & Mori M. AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins. Journal of Cell Biology 2003 163 45-56.
Hollingshead BD, Patel RD & Perdew GH. Endogenous hepatic expression of the hepatitis B virus X-associated protein 2 is adequate for maximal association with aryl hydrocarbon receptor-90-kDa heat shock protein complexes. Molecular Pharmacology 2006 70 2096-2107.
Petersen SL, Krishnan S & Hudgens ED. The aryl hydrocarbon receptor pathway and sexual differentiation of neuroendocrine functions. Endocrinology 2006 147 S33-S42.
Den Hond E & Schoeters G. Endocrine disrupters and human puberty. International Journal of Andrology 2006 29 264-271.
Beischlag TV & Perdew GH. ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. Journal of Biological Chemistry 2005 280 21607-21611.
Fan M, Park A & Nephew KR CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. Molecular Endocrinology 2005 19 2901-2914.
Morales JL & Perdew GH. Carboxyl terminus of hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90 kDa heat-shock protein (hsp90) in vitro. Biochemistry 2007 46 610-621.
Gioiosa L, Fissore E, Ghirardelli G, Pannigiani S & Palanza P. Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice. Hormones and Behaviour 2007 52 307-316.
Franczak A, Nynca A, Valdez KE, Mizinga KM & Petroff BK. Effects of acute and chronic exposure to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin on the transition to reproductive senescence in female Sprague-Dawley rats. Biology of Reproduction 2006 74 125-130.
Gray LE Jr & Ostby JS. In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicology and Applied Pharmacology 1995 133 285-294.
Baba T, Mimura J, Nakamura N, Harada N, Yamamoto M, Morohashi K & Fujii-Kuriyama Y. Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. Molecular Cell Biology 2005 25 10040-10051.
Merisalu A, Punab M, Altmae S, Haller K, Tiido T, Peters M & Salumets A. The contribution of genetic variations of aryl hydrocarbon receptor pathway genes to male factor infertility. Fertility and Sterility 2007 In Press.
Tsuchiya M, Katoh T, Motoyarna H, Sasaki H, Tsugane S & Ikenoue T. Analysis of the AhR, ARn and AhRR gene polymorphisms: genetic contribution to endometriosis susceptibility and severity. Fertility and Sterility 2005 84 454-458.
Elango A, Shepherd B & Chen TT. Effects of endocrine disrupters on the expression of growth hormone and prolactin mRNA in the rainbow trout pituitary. General and Comparative Endocrinology 2006 145 116-127.
Gonzalez-Parra S, Argente J, Garcia-Segura LM & Chowen JA. Cellular composition of the adult rat anterior pituitary is influenced by the neonatal sex steroid environment. Neuroendocrinology 1998 68 152-162.
Gonzalez-Parra S, Chowen JA, Garcia-Segura LM & Argente J. In vivo and in vitro regulation of pituitary transcription factor-1 (Pit-1) by changes in the hormone environment. Neuroendocrinology 1996 63 3-15.
Rasier G, Toppari J, Parent AS & Bourguignon JP. Female sexual maturation and reproduction after prepubertal exposure to estrogens and endocrine disrupting chemicals: a review of rodent and human data. Molecular and Cellular Endocrinology 2006 255 187-201.
